At the news
? BEARISHIMPACT 6/10 CLUSTER filed Apr 16, 2026 at 16:31 ET
Four corporate insiders at United Therapeutics, including the CEO, CFO, and General Counsel, conducted open-market share sales totaling $1.29 million over a 7-day window, following derivative exercises. The net direction is clearly selling, with the largest individual sale by a director accounting for nearly half the total value.
- CEO Martine Rothblatt sold $89,732 in open-market transactions and exercised derivatives worth over $3.8 million in non-cash transactions.
- CFO James Edgemond sold $503,649 in shares after exercising options valued at $2.7 million.
- Director Christopher Patusky sold $578,880 of shares, the largest single transaction in the cluster.
- General Counsel Paul Mahon sold $114,807 in shares following derivative exercises worth $1.2 million.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access